Learn More
Description
EBV LMP2 peptide CLGGLLTMV (HLA-A*0201) is a single peptide for stimulation of T cells. The peptide from human Epstein-Barr virus (EBV) latent membrane protein 2 (LMP2) is synthesized as it is presented by the MHC class I HLA-A*0201 allele and can be used for targeted in vitro generation and expansion of antigen-specific CD8+ T cells.
- Peptides have been purified by HPLC using a water and acetonitrile gradient
- Endotoxin-free
Specifications
Specifications
| Purity | >85% |
| Endotoxin Level | Endotoxin-free |
| For Use With (Application) | T Cell Stimulation |
| Lyophilized | Yes |
| Quantity | 1 mg |
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.